Neurophysiologic and intellectual evaluation of beta-thalassemia patients

Brain and Development

Volumn 28, Issue 1, 2006, Pages 14-18

  Economou, Marina ^a   Zafeiriou, Dimitrios I ^a   Kontopoulos, Eleftherios ^a   Gompakis, Nikos ^a   Koussi, Aphroditi ^a   Perifanis, Vasilios ^a   Athanassiou Metaxa, Miranda ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Beta thalassemia; Cognitive dysfunction; Desferrioxamine; Evoked potentials; Intelligence quotient; Nerve conduction velocity; Neurophysiology; Neurotoxicity

Indexed keywords

DEFEROXAMINE; FERRITIN;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CENTRAL NERVOUS SYSTEM; CHELATION; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; FERRITIN BLOOD LEVEL; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MENTAL DEFICIENCY; MOTOR NERVE CONDUCTION; NEUROPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; SENSORY NERVE CONDUCTION; VERBAL BEHAVIOR; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BETA-THALASSEMIA; CHILD; DEFEROXAMINE; EVOKED POTENTIALS; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SIDEROPHORES;

EID: 29944437640     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2005.03.006     Document Type: Article

References (26)

1. M. Fosburg, and D. Nathan Treatment of Cooley's anemia Blood 76 1990 435 444
2. B. Modell, M. Khan, and M. Darlison Survival in beta-thalassemia major in the UK: data from the UK Thalassemia Register Lancet 355 2000 2051 2052
3. N. Olivieri, and G. Brittengham Iron chelation therapy and the treatment of thalassemia Blood 89 1997 739 761
4. U. Ambrosetti, E. Donde, G. Piatti, and M. Capellini Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment Pharmacol Res 42 2000 485 487
5. A. Chiodo, P. Alberti, G. Sher, W. Francombe, and B. Tayler Desferrioxamine ototoxicity in an adult transfusion dependent population J Otolaryngol 26 1997 116 122
6. C. Borgna-Pignati, P. De Stefano, and A. Broglia Visual loss in patient on high-dose subcutaneous desferrioxamine Lancet 1 1984 681
7. S. De Virgiliis, M. Congia, M. Turco, F. Frau, C. Dessi, and F. Argiolou Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassemia Arch Dis Child 63 1988 250 255
8. J. Porter A risk-benefit assessment of iron-chelation therapy Drug Saf 17 1997 407 421
9. N. Olivieri, J. Buncic, E. Chew, T. Gallant, R. Harrison, and N. Keenan Visual and auditory neurotoxicity in patients receiving subcutaneous desferrioxamine infusions New Engl J Med 314 1986 869 873
10. J. Porter, M. Jawson, East C. Huehns, and J. Hazell Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage Br J Haematol 73 1989 403 409
11. B. Wonke, A. Hoffbrand, M. Aldouri, D. Wickens, D. Flynn, and M. Stearns Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA Arch Dis Child 64 1989 77 82
12. B. Aarabi, M. Haghshenas, and V. Rakeii Visual failure caused by suprasellar extramedullary hematopoiesis in beta thalassemia: case report Neurosurgery 42 1998 922 925
13. A. Cohen, M. Martin, J. Mizanin, D. Konkle, and E. Schwartz Vision and hearing during deferoxamine therapy J Pediatr 117 1990 326 330
14. V. Wong, A. Li, and A. Lee Neurophysiologic study of beta-thalassemia patients J Child Neurol 8 1993 330 335
15. G. Incorpora, F. Di Gregorio, M. Romeo, P. Pavone, R. Trifiletti, and E. Parano Focal neurologic deficits in children with beta-thalassemia major Neuropediatrics 30 1999 45 48
16. D. Georgas, I. Paraskevopoulos, I. Bezebegis, and N. Giannitsas Weschler Intelligence Scale for Children-III-Manual Greek ed 1997 Hellenic Letters Athens
17. F. Cai, and J. Zhang Study of nerve conduction and late responses in normal Chinese infants, children and adults J Child Neurol 12 1997 13 18
18. C. Gelmi, C. Borgna-Pignatti, S. Franchin, M. Tacchini, and F. Trimarchi Electroretinographic and visual evoked potential abnormalities in patients with beta-thalassemia major Ophthalmologica 196 1988 29 34
19. Y. Bentur, G. Koren, A. Tesoro, H. Carley, N. Olivieri, and M. Freedman Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity Clin Pharmacol Ther 47 1990 478 482
20. G. Amabile, E. Stefano, I. Bianco, M. Aliquo, P. Giunti, and F. Pierelli Electrophysiological study in patients with beta-thalassemia major Acta Neurol 87 1987 181 190
21. D. Zafeiriou, A. Kousi, C. Tsantali, E. Kontopoulos, P. Augoustidou-Savvopoulou, and P. Tsoubaris Neurophysiologic evaluation of long-term desferrioxamine therapy in beta-thalassemia patients Pediatr Neurol 18 1998 420 424
22. D. Papanastasiou, D. Papanicolaou, A. Magiakou, N. Beratis, E. Tzebelikos, and T. Papapetropoulos Peripheral neuropathy in patients with beta-thalassemia J Neurol Neurosurg Psychiatry 54 1991 997 1000
23. C. Davidson, and I. Weschler Erythroblastic (Cooley's) anemia and neurologic complications Am J Dis Child 58 1939 362 365
24. Y. Matoth, Z. Shamir, and E. Freunollich Thalassemia in Jews from Kurdistan Blood 10 1955 176 178
25. J. Logothetis, M. Haritos, M. Constantoulakis, J. Economidou, O. Augoustaki, and R. Lowenson Intelligence and behavioral patterns in patients with Cooley's anemia; a study based on 138 consecutive cases Pediatrics 48 1971 740 744
26. R. Monastero, G. Monastero, C. Ciaccio, A. Padovani, and R. Camadra Cognitive deficits in beta-thalassemia major Acta Neurol Scand 102 2000 162 168